feed,title,long_url,short_url
Benzinga,"Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?",https://benzinga.com/general/biotech/21/07/22005954/moderna-is-now-more-valued-than-gilead-glaxosmithkline-how-long-did-covid-19-vaccine-maker-take-t,https://j.mp/3kpzpxk
